Title : Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement.

Pub. Date : 2009 Dec

PMID : 19890703






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 DISCUSSION: The key role of platelet-mediated thrombosis in the pathogenesis of NSTE ACS is confirmed by the proven clinical benefits of antiplatelet agents (aspirin and a P2Y(12) adenosine diphosphate [ADP] receptor antagonist) in this setting. Aspirin 1-aminocyclopropane-1-carboxylate synthase homolog (inactive) Homo sapiens